Legal & General Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $47.2K | Sell |
|
|||||
|
2025
Q1 | $77.5K | Sell |
|
|||||
|
2024
Q4 | $358K | Buy |
|
|||||
|
2024
Q3 | $445K | Buy |
|
|||||
|
2024
Q2 | $642K | Sell |
|
|||||
|
2024
Q1 | $1.12M | Buy |
|
|||||
|
2023
Q4 | $1.26M | Buy |
|
|||||
|
2023
Q3 | $1.18M | Sell |
|
|||||
|
2023
Q2 | $2.72M | Buy |
|
|||||
|
2023
Q1 | $2.11M | Buy |
|
|||||
|
2022
Q4 | $1.72M | Sell |
|
|||||
|
2022
Q3 | $1.77M | Sell |
|
|||||
|
2022
Q2 | $1.58M | Sell |
|
|||||
|
2022
Q1 | $3.06M | Buy |
|
|||||
|
2021
Q4 | $3.65M | Sell |
|
|||||
|
2021
Q3 | $4.15M | Buy |
|
|||||
|
2021
Q2 | $4.75M | Buy |
|
|||||
|
2021
Q1 | $2.4M | Buy |
|
|||||
|
2020
Q4 | $2.73M | Sell |
|
|||||
|
2020
Q3 | $2.59M | Buy |
|
|||||
|
2020
Q2 | $1.74M | Buy |
|
|||||
|
2020
Q1 | $1.13M | Sell |
|
|||||
|
2019
Q4 | $2.86M | Buy |
|
|||||
|
2019
Q3 | $4.86M | Buy |
|
|||||
|
2019
Q2 | $5.5M | Buy |
|
|||||
|
2019
Q1 | $4.05M | Buy |
|
|||||
|
2018
Q4 | $2.21M | Buy |
|
|||||
|
2018
Q3 | $2.98M | Buy |
|
|||||
|
2018
Q2 | $3.31M | Buy |
|
|||||
|
2018
Q1 | $2.83M | Buy |
|
|||||
|
2017
Q4 | $2.8M | Buy |
|
|||||
|
2017
Q3 | $924K | Buy |
|
|||||
|
2017
Q2 | $969K | Buy |
|
|||||
|
2017
Q1 | $755K | Buy |
|
|||||
|
2016
Q4 | $497K | Buy |
|
|||||
|
2016
Q3 | $262K | Buy |
|
|||||
|
2016
Q2 | $157K | Buy |
|
|||||
|
2016
Q1 | $134K | Buy |
|
|||||
|
2015
Q4 | $205K | Buy |
|
|||||
|
2015
Q3 | $96K | Hold |
|
|||||
|
2015
Q2 | $163K | Buy |
|